{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:30Z","timestamp":1787020110105,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U25A20108 and 82173028"],"award-info":[{"award-number":["U25A20108 and 82173028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"DOI":"10.1186\/s12891-026-10030-9","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:12:45Z","timestamp":1781133165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and prognostic factors for spinal metastasis from sarcomatoid carcinoma: identifying candidates suitable for surgical intervention"],"prefix":"10.1186","volume":"27","author":[{"given":"Enyuan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianru","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"3","key":"10030_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.21037\/tlcr-24-127","volume":"13","author":"Y Wei","year":"2024","unstructured":"Wei Y, Wang L, Jin Z, et al. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review. Transl Lung Cancer Res. 2024;13(3):635\u201353. https:\/\/doi.org\/10.21037\/tlcr-24-127.","journal-title":"Transl Lung Cancer Res"},{"issue":"7","key":"10030_CR2","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1007\/s12094-024-03823-8","volume":"27","author":"Z Du","year":"2025","unstructured":"Du Z, Qin Y, Lv Y, et al. Clinical characteristics and survival outcomes in patients with pulmonary sarcomatoid carcinoma: a multicenter retrospective study. Clin Transl Oncol. 2025;27(7):2993\u20133000. https:\/\/doi.org\/10.1007\/s12094-024-03823-8.","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"10030_CR3","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/ijc.34680","volume":"153","author":"R Morisue","year":"2023","unstructured":"Morisue R, Kojima M, Suzuki T, et al. Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology-based cross-organ study. Int J Cancer. 2023;153(12):1997\u20132010. https:\/\/doi.org\/10.1002\/ijc.34680.","journal-title":"Int J Cancer"},{"issue":"11","key":"10030_CR4","doi-asserted-by":"publisher","first-page":"8621","DOI":"10.1097\/JS9.0000000000002948","volume":"111","author":"J Ji","year":"2025","unstructured":"Ji J, Hu D, Wang J, et al. Prognostic impact of adjuvant therapy following surgical resection in primary hepatic sarcomatoid carcinoma: a retrospective cohort study. Int J Surg. 2025;111(11):8621\u20135. https:\/\/doi.org\/10.1097\/JS9.0000000000002948.","journal-title":"Int J Surg"},{"key":"10030_CR5","doi-asserted-by":"publisher","unstructured":"Fan J, Chen L, Li CH, Xiao ZY, Zhou SH. Laryngeal sarcomatoid carcinoma: a case report and literature review on potential molecular targets for therapeutic opportunities. Front Oncol. 2025;151549790. https:\/\/doi.org\/10.3389\/fonc.2025.1549790.","DOI":"10.3389\/fonc.2025.1549790"},{"key":"10030_CR6","doi-asserted-by":"publisher","unstructured":"Fuentes HE, Suleiman R, Graham RP, et al. Outcomes and molecular profiles in sarcomatoid carcinoma of unknown primary: the Mayo Clinic experience. Oncologist. 2025;30(8). https:\/\/doi.org\/10.1093\/oncolo\/oyae333.","DOI":"10.1093\/oncolo\/oyae333"},{"issue":"1","key":"10030_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1186\/s12885-019-6155-6","volume":"19","author":"RW Huey","year":"2019","unstructured":"Huey RW, Makawita S, Xiao L, et al. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. BMC Cancer. 2019;19(1):965. https:\/\/doi.org\/10.1186\/s12885-019-6155-6.","journal-title":"BMC Cancer"},{"issue":"8","key":"10030_CR8","doi-asserted-by":"publisher","first-page":"105343","DOI":"10.1016\/j.esmoop.2025.105343","volume":"10","author":"K Amrane","year":"2025","unstructured":"Amrane K, Cabarrou B, Justeau G, et al. Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis. ESMO Open. 2025;10(8):105343. https:\/\/doi.org\/10.1016\/j.esmoop.2025.105343.","journal-title":"ESMO Open"},{"issue":"12","key":"10030_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jtho.2025.07.121","volume":"20","author":"L Hong","year":"2025","unstructured":"Hong L, Di Federico A, Liu B, et al. Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study. J Thorac Oncol. 2025;20(12):1763\u201377. https:\/\/doi.org\/10.1016\/j.jtho.2025.07.121.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10030_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.21037\/jtd-20-2826","volume":"13","author":"C Xiao","year":"2021","unstructured":"Xiao C, Yang X, Hao J, et al. Clinicopathological features and prognostic analysis of metastatic pulmonary sarcomatoid carcinoma: a SEER analysis. J Thorac Dis. 2021;13(2):893\u2013905. https:\/\/doi.org\/10.21037\/jtd-20-2826.","journal-title":"J Thorac Dis"},{"key":"10030_CR11","doi-asserted-by":"publisher","unstructured":"Ullah A, Ahmed A, Yasinzai AQK, et al. Demographics and Clinicopathologic Profile of Pulmonary Sarcomatoid Carcinoma with Survival Analysis and Genomic Landscape. Cancers (Basel). 2023;15(9). https:\/\/doi.org\/10.3390\/cancers15092469.","DOI":"10.3390\/cancers15092469"},{"key":"10030_CR12","doi-asserted-by":"publisher","unstructured":"Wang T, Liu J, Wu Z, et al. Surgical Outcome and Prognosis of Patients with Spinal Metastasis from Esophageal Cancer: The Experience from a Single Center. World Neurosurg. 2023;e176521\u2013534. https:\/\/doi.org\/10.1016\/j.wneu.2023.05.092.","DOI":"10.1016\/j.wneu.2023.05.092"},{"key":"10030_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-025-09004-7","author":"H Lin","year":"2025","unstructured":"Lin H, Wang T, Sun J, et al. Treatments and outcomes of primary and metastatic spinal angiosarcoma patients: study of 29 consecutive cases. Eur Spine J. 2025. https:\/\/doi.org\/10.1007\/s00586-025-09004-7.","journal-title":"Eur Spine J"},{"key":"10030_CR14","doi-asserted-by":"publisher","unstructured":"Palacio Giraldo A, Dammerer V, Neugebauer J, et al. Current Concepts in the Management and Treatment of Spinal Metastases-A Systematic Literature Review. Cancers (Basel). 2025;17(8). https:\/\/doi.org\/10.3390\/cancers17081296.","DOI":"10.3390\/cancers17081296"},{"key":"10030_CR15","doi-asserted-by":"publisher","unstructured":"Xu K, Li J, Hu M, et al. Prognostic Significance of Preoperative Inflammatory Biomarkers and Traditional Clinical Parameters in Patients with Spinal Metastasis from Clear Cell Renal Cell Carcinoma: A Retrospective Study of 95 Patients in a Single Center. Cancer Manag Res. 2020;1259\u201370. https:\/\/doi.org\/10.2147\/CMAR.S228570.","DOI":"10.2147\/CMAR.S228570"},{"issue":"1","key":"10030_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1186\/s12885-024-12728-2","volume":"24","author":"K Kaseda","year":"2024","unstructured":"Kaseda K, Asakura K, Shintani Y, et al. Surgically resected sarcomatoid carcinoma of the lung: a nationwide retrospective study in 2010. BMC Cancer. 2024;24(1):938. https:\/\/doi.org\/10.1186\/s12885-024-12728-2.","journal-title":"BMC Cancer"},{"issue":"3","key":"10030_CR17","doi-asserted-by":"publisher","first-page":"e14123","DOI":"10.1016\/j.heliyon.2023.e14123","volume":"9","author":"L Chen","year":"2023","unstructured":"Chen L, Ruan S, Wang P, et al. Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study. Heliyon. 2023;9(3):e14123. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14123.","journal-title":"Heliyon"},{"issue":"3","key":"10030_CR18","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00261-025-05156-8","volume":"51","author":"L Lu","year":"2026","unstructured":"Lu L, Zhang R, Pan X, et al. Clinical and imaging comparison of primary liver carcinosarcoma and sarcomatoid carcinoma. Abdom Radiol (NY). 2026;51(3):1383\u201396. https:\/\/doi.org\/10.1007\/s00261-025-05156-8.","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"10030_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.crad.2020.01.003","volume":"75","author":"S Zhao","year":"2020","unstructured":"Zhao S, Su W, Deng L, et al. Pancreatic sarcomatoid carcinoma: CT, MRI, and (18)F-FDG PET\/CT features. Clin Radiol. 2020;75(5):397. https:\/\/doi.org\/10.1016\/j.crad.2020.01.003. e397\u2013397 e314.","journal-title":"Clin Radiol"},{"issue":"8","key":"10030_CR20","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1111\/1759-7714.13468","volume":"11","author":"X Xie","year":"2020","unstructured":"Xie X, Tu N, Wang Q, et al. (18) F-FDG PET\/CT imaging of small intestinal metastasis from pulmonary sarcomatoid carcinoma: Brief report and review of the literature. Thorac Cancer. 2020;11(8):2325\u201330. https:\/\/doi.org\/10.1111\/1759-7714.13468.","journal-title":"Thorac Cancer"},{"key":"10030_CR21","doi-asserted-by":"publisher","unstructured":"Luo ZH, Luo XY, Qi WL, Liu Q. (18)F-FDG PET\/CT imaging in pulmonary sarcomatoid carcinoma. Front Oncol. 2024;141334156. https:\/\/doi.org\/10.3389\/fonc.2024.1334156.","DOI":"10.3389\/fonc.2024.1334156"},{"issue":"6","key":"10030_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/imt-2023-0243","volume":"16","author":"S Radhakrishnan","year":"2024","unstructured":"Radhakrishnan S, Martin CA, Vij M, et al. Treatment and prognostic implications of strong PD-L1 expression in primary hepatic sarcomatoid carcinoma. Immunotherapy. 2024;16(6):371\u20139. https:\/\/doi.org\/10.2217\/imt-2023-0243.","journal-title":"Immunotherapy"},{"issue":"11","key":"10030_CR23","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.21037\/tlcr-2025-886","volume":"14","author":"Q Wang","year":"2025","unstructured":"Wang Q, Guo H, Wang Y, et al. The pathogenesis and therapeutic management of rare pulmonary sarcomatoid carcinoma: a narrative review. Transl Lung Cancer Res. 2025;14(11):5137\u201358. https:\/\/doi.org\/10.21037\/tlcr-2025-886.","journal-title":"Transl Lung Cancer Res"},{"key":"10030_CR24","doi-asserted-by":"publisher","unstructured":"Zhang M, Li X, Huang Z, Yang Z, Yang L. Outstanding treatment success of pembrolizumab and bevacizumab combination therapy in first-line treatment of cervical sarcomatoid carcinoma: a rare case report. Front Oncol. 2025;151586531. https:\/\/doi.org\/10.3389\/fonc.2025.1586531.","DOI":"10.3389\/fonc.2025.1586531"},{"key":"10030_CR25","doi-asserted-by":"publisher","unstructured":"Zombori-Toth N, Kiss S, Ostarijas E, Alizadeh H, Zombori T. Adjuvant chemotherapy could improve the survival of pulmonary sarcomatoid carcinoma: A systematic review and meta-analysis. Surg Oncol. 2022;44101824. https:\/\/doi.org\/10.1016\/j.suronc.2022.101824.","DOI":"10.1016\/j.suronc.2022.101824"},{"issue":"6","key":"10030_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2217\/fon-2021-1071","volume":"18","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Fu Y, Zhong Q, Deng R, Zhang Y. The treatment of advanced pulmonary sarcomatoid carcinoma. Future Oncol. 2022;18(6):727\u201338. https:\/\/doi.org\/10.2217\/fon-2021-1071.","journal-title":"Future Oncol"},{"key":"10030_CR27","doi-asserted-by":"publisher","unstructured":"Du H, Song X, Wu F. Evaluation of the Effectiveness and Safety Profile of First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy in Pulmonary Sarcomatoid Carcinoma. Lung Cancer (Auckl). 2025;1673\u201383. https:\/\/doi.org\/10.2147\/LCTT.S494990.","DOI":"10.2147\/LCTT.S494990"},{"key":"10030_CR28","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096341070250109074108","author":"D Liao","year":"2025","unstructured":"Liao D, Liu J, Jin Q, et al. A Review of the Progress in the Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma. Curr Cancer Drug Targets. 2025. https:\/\/doi.org\/10.2174\/0115680096341070250109074108.","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"10030_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/RLU.0000000000006234","volume":"51","author":"X Liu","year":"2026","unstructured":"Liu X, Zhao Y, Tian C, Wang W, Chen Y. A case of sarcomatoid carcinoma of the lung treated with a new radiopharmaceutical 225Ac-DOTA-IBA. Clin Nucl Med. 2026;51(3):268\u201370. https:\/\/doi.org\/10.1097\/RLU.0000000000006234.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"10030_CR30","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.21037\/jtd-2025-1149","volume":"17","author":"C Chen","year":"2025","unstructured":"Chen C, Xu L, Li W, et al. Clinical characteristics and treatment challenges of esophageal sarcomatoid carcinoma: a single-center retrospective cohort study. J Thorac Dis. 2025;17(10):8171\u201380. https:\/\/doi.org\/10.21037\/jtd-2025-1149.","journal-title":"J Thorac Dis"},{"key":"10030_CR31","doi-asserted-by":"publisher","unstructured":"Zou RQ, Hu HJ, Lv TR, et al. Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma of the gallbladder. Front Oncol. 2022;121009673. https:\/\/doi.org\/10.3389\/fonc.2022.1009673.","DOI":"10.3389\/fonc.2022.1009673"},{"issue":"3","key":"10030_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.21037\/jtd.2019.02.02","volume":"11","author":"YW Seong","year":"2019","unstructured":"Seong YW, Han SJ, Jung W, et al. Perioperative change in neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor in patients with completely resected primary pulmonary sarcomatoid carcinoma. J Thorac Dis. 2019;11(3):819\u201326. https:\/\/doi.org\/10.21037\/jtd.2019.02.02.","journal-title":"J Thorac Dis"},{"issue":"1","key":"10030_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00405-021-06800-x","volume":"279","author":"R Patil","year":"2022","unstructured":"Patil R, Pandit P, Palwe V, et al. The predictive role of neutrophil-to-lymphocyte ratio in the outcomes of patients with sarcomatoid carcinoma of oral cavity. Eur Arch Otorhinolaryngol. 2022;279(1):433\u201341. https:\/\/doi.org\/10.1007\/s00405-021-06800-x.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10030_CR34","doi-asserted-by":"publisher","unstructured":"Heshmat-Ghahdarijani K, Sarmadi V, Heidari A, et al. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Front Oncol. 2023;131228076. https:\/\/doi.org\/10.3389\/fonc.2023.1228076.","DOI":"10.3389\/fonc.2023.1228076"},{"key":"10030_CR35","doi-asserted-by":"publisher","unstructured":"Wahnou H, El Kebbaj R, Hba S, et al. Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy. Cancers (Basel). 2025;17(7). https:\/\/doi.org\/10.3390\/cancers17071232.","DOI":"10.3390\/cancers17071232"},{"key":"10030_CR36","doi-asserted-by":"publisher","unstructured":"Mosca M, Nigro MC, Pagani R, De Giglio A, Di Federico A. Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond. Biomolecules. 2023;13(12). https:\/\/doi.org\/10.3390\/biom13121803.","DOI":"10.3390\/biom13121803"},{"issue":"22","key":"10030_CR37","doi-asserted-by":"publisher","first-page":"e38463","DOI":"10.1097\/MD.0000000000038463","volume":"103","author":"X Li","year":"2024","unstructured":"Li X, Ren H, Peng L, Li J. Prognostic value of pretreatment platelet count, fibrinogen and d-dimer levels in osteosarcoma patients: A meta-analysis. Med (Baltim). 2024;103(22):e38463. https:\/\/doi.org\/10.1097\/MD.0000000000038463.","journal-title":"Med (Baltim)"},{"issue":"1","key":"10030_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12876-025-04532-4","volume":"26","author":"X Cheng","year":"2025","unstructured":"Cheng X, Zhang Y, Li X, Xu Z, Chen Y. Relationship of D-dimer with survival and metastasis in gastric cancer patients: a meta-analysis and systematic review. BMC Gastroenterol. 2025;26(1):30. https:\/\/doi.org\/10.1186\/s12876-025-04532-4.","journal-title":"BMC Gastroenterol"},{"key":"10030_CR39","doi-asserted-by":"publisher","unstructured":"Shen Y, Wang J, Hua Q, Dong M. The Predictive Value of NLR, PLR, LMR, NPAR and D-Dimer on the Efficacy and Prognosis of First-Line Immunotherapy for Extensive-Stage Small Cell Lung Cancer. J Inflamm Res. 2025;1817211\u201317222. https:\/\/doi.org\/10.2147\/JIR.S557312.","DOI":"10.2147\/JIR.S557312"},{"issue":"10","key":"10030_CR40","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.21037\/jtd-22-1363","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Lu D, Zhang Z, et al. Prognostic value of plasma D-dimer levels in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a retrospective study. J Thorac Dis. 2022;14(10):4125\u201335. https:\/\/doi.org\/10.21037\/jtd-22-1363.","journal-title":"J Thorac Dis"},{"issue":"15","key":"10030_CR41","doi-asserted-by":"publisher","first-page":"15831","DOI":"10.1002\/cam4.6222","volume":"12","author":"C Chen","year":"2023","unstructured":"Chen C, Yin H, Zhang Y, et al. Plasma D-dimer and interleukin-6 are associated with treatment response and progression-free survival in advanced NSCLC patients on anti-PD-1 therapy. Cancer Med. 2023;12(15):15831\u201340. https:\/\/doi.org\/10.1002\/cam4.6222.","journal-title":"Cancer Med"},{"issue":"1","key":"10030_CR42","doi-asserted-by":"publisher","first-page":"2620195","DOI":"10.1080\/07853890.2026.2620195","volume":"58","author":"F Li","year":"2026","unstructured":"Li F, Zha J, Hu M, Zhang W. Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer. Ann Med. 2026;58(1):2620195. https:\/\/doi.org\/10.1080\/07853890.2026.2620195.","journal-title":"Ann Med"},{"key":"10030_CR43","doi-asserted-by":"publisher","unstructured":"Li X, Gao L, Wang B, et al. FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription. J Immunother Cancer. 2024;12(7). https:\/\/doi.org\/10.1136\/jitc-2024-009565.","DOI":"10.1136\/jitc-2024-009565"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-026-10030-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10030-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10030-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:28:47Z","timestamp":1787016527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-026-10030-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10030"],"URL":"https:\/\/doi.org\/10.1186\/s12891-026-10030-9","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research project was examined and approved by the medical ethics committee of Shanghai Changzheng Hospital in accordance with the Declaration of Helsinki (2018SL004), and written informed consent was obtained from all patients or their legal guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"705"}}